Gsk Plc-spon Adr. Earnings

Gsk Plc-spon Adr.’s revenue jumped 4.79% since last year same period to $8505.9Mn in the Q4 2025. On a quarterly growth basis, Gsk Plc-spon Adr. has generated -0.48% fall in its revenue since last 3-months.

Gsk Plc-spon Adr.’s net profit jumped 51.62% since last year same period to $627.73Mn in the Q4 2025. On a quarterly growth basis, Gsk Plc-spon Adr. has generated -68.82% fall in its net profits since last 3-months.

Gsk Plc-spon Adr.’s net profit margin jumped 44.69% since last year same period to 7.38% in the Q4 2025. On a quarterly growth basis, Gsk Plc-spon Adr. has generated -68.67% fall in its net profit margins since last 3-months.

Gsk Plc-spon Adr.’s earning per share (EPS) estimates for the current quarter stand at 1.2 - a 88.15% jump from last quarter’s estimates.

Gsk Plc-spon Adr.’s earning per share (EPS) estimates for the current year stand at 1.2.

Gsk Plc-spon Adr.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Gsk Plc-spon Adr. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Gsk Plc-spon Adr. declared 0.49 dividend per share during the earnings announcement for Q1 2026.